TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35039313

Group type: EXPERIMENTAL
Intervention: Home-based exercise and self-management programme (12-week programme)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Usual care (no exercise programme)
Number of subjects: 112
Study: 33222472

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiation therapy (40 Gy in 15 fractions) concomitantly with temozolomide (TMZ) followed by adjuvant TMZ
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radiation therapy alone
Number of subjects: 0
Study: 32675772

Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg plus Rilpivirine 25 mg (early-switch group)
Number of subjects: 990

Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg plus Rilpivirine 25 mg (late-switch group)
Number of subjects: 990

Group type: EXPERIMENTAL
Intervention: Dolutegravir plus Rilpivirine (both groups)
Number of subjects: 990

Group type: EXPERIMENTAL
Intervention: Dolutegravir plus Rilpivirine (early-switch group)
Number of subjects: 990

Group type: EXPERIMENTAL
Intervention: Dolutegravir plus Rilpivirine (late-switch group)
Number of subjects: 990

Group type: EXPERIMENTAL
Intervention: Participants taking Tenofovir disoproxil fumarate pre-switch
Number of subjects: 990

Group type: EXPERIMENTAL
Intervention: Participants taking Dolutegravir plus Rilpivirine
Number of subjects: 990
Study: 34392403

Group type: EXPERIMENTAL
Intervention: Ethanolic extract of propolis type-3 3% (EEP)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Chlorhexidine 0.12% (CHX)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 10
Study: 33693741

Group type: EXPERIMENTAL
Intervention: Galacto-Oligosaccharides (GOS) with iron fortified maize porridge (5 mg iron as FeFum + NaFeEDTA)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Galacto-Oligosaccharides (GOS) with iron fortified maize porridge (5 mg iron as FeSO4)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Iron fortified maize porridge (5 mg iron as FeFum + NaFeEDTA) without GOS
Number of subjects: 23

Group type: COMPARATOR
Intervention: Iron fortified maize porridge (5 mg iron as FeSO4) without GOS
Number of subjects: 23
Study: 32757651

Group type: EXPERIMENTAL
Intervention: Greater PARP activity
Number of subjects: 3149

Group type: EXPERIMENTAL
Intervention: Genetically predicted elevation in PARP activity
Number of subjects: 3149
Study: 35174415

Group type: EXPERIMENTAL
Intervention: High frequency stimulation (HF)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 29
Study: 34304674

Group type: EXPERIMENTAL
Intervention: Mogamulizumab (1.0 mg/kg intravenously weekly)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vorinostat (400 mg orally daily)
Number of subjects: 0
Study: 35891246

Group type: EXPERIMENTAL
Intervention: Two doses of CoronaVac® with 14 days between doses
Number of subjects: 2302

Group type: EXPERIMENTAL
Intervention: Two doses of CoronaVac® with 28 days between doses
Number of subjects: 2302

Group type: EXPERIMENTAL
Intervention: Both schedules of CoronaVac®
Number of subjects: 2302
Study: 32891160

Group type: EXPERIMENTAL
Intervention: Gum Arabic (GA) 30-grams-dose once daily for four weeks
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Gum Arabic (GA)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo (pectin powder 1-gram-dose once daily for four weeks)
Number of subjects: 110
Study: 33952313

Group type: EXPERIMENTAL
Intervention: Mental health specialist video consultations
Number of subjects: 320

Group type: COMPARATOR
Intervention: Treatment as usual by the GP
Number of subjects: 320
Study: 32592986

Group type: EXPERIMENTAL
Intervention: Fruquintinib
Number of subjects: 527

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: Fruquintinib (post hoc analysis)
Number of subjects: 527

Group type: COMPARATOR
Intervention: Placebo (post hoc analysis)
Number of subjects: 527
Study: 35363632

Group type: EXPERIMENTAL
Intervention: Virtual reality simulation teaching process (n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional workshop (control group, n = 50)
Number of subjects: 100
Study: 33619667

Group type: EXPERIMENTAL
Intervention: Life-Sustaining Treatment (LST) for severe disability scenario
Number of subjects: 1588

Group type: EXPERIMENTAL
Intervention: Life-Sustaining Treatment (LST) for vegetative state scenario
Number of subjects: 1588

Group type: EXPERIMENTAL
Intervention: Predictors for LST selection in severe disability scenario
Number of subjects: 1588

Group type: EXPERIMENTAL
Intervention: Predictors for LST selection in vegetative state scenario
Number of subjects: 1588
Study: 35624520

Group type: EXPERIMENTAL
Intervention: Home-based, virtual exercise intervention (telehealth exercise) consisting of two online group exercise sessions per week for 10 weeks, each session lasting 30 minutes and including aerobic and resistance exercise at moderate intensity.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Home-based, virtual exercise intervention (telehealth exercise)
Number of subjects: 20
Study: 32907638

Group type: EXPERIMENTAL
Intervention: Sarilumab plus Standard of Care
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard of Care
Number of subjects: 30
Study: 35927757

Group type: EXPERIMENTAL
Intervention: Vitamin D and synbiotic
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Vitamin D placebo and synbiotic
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Vitamin D and synbiotic placebo
Number of subjects: 88

Group type: COMPARATOR
Intervention: Vitamin D placebo and synbiotic placebo
Number of subjects: 88
Study: 33713756

Group type: EXPERIMENTAL
Intervention: Multimodal nonopioid analgesic protocol
Number of subjects: 61

Group type: COMPARATOR
Intervention: Standard opioid regimen
Number of subjects: 61
Study: 33047918

Group type: COMPARATOR
Intervention: Monopolar transurethral resection of the prostate (M-TURP)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Bipolar plasmakinetic transurethral resection of the prostate (PK-TURP)
Number of subjects: 84
Study: 32144926

Group type: EXPERIMENTAL
Intervention: Head-nine-needle therapy
Number of subjects: 150

Group type: COMPARATOR
Intervention: Acupuncture control
Number of subjects: 150

Group type: COMPARATOR
Intervention: Western medicine control (epiperisone hydrochloride and fluoguili hydrochloride)
Number of subjects: 150
Study: 34507355

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFNα)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Hydroxyurea
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 202
Study: 33376120

Group type: EXPERIMENTAL
Intervention: One-week interval oral health intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-week interval oral health intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 35232793

Group type: EXPERIMENTAL
Intervention: US branded packs without GWLs
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: non‐branded packs without GWLs (Blank)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: rotating non‐branded packs with GWLs (gangrene; throat cancer; neonatal baby)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: gangrene‐GWL pack
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Blank pack
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: GWLs (blindness, teeth) not used in trial
Number of subjects: 287
Study: 34454817

Group type: EXPERIMENTAL
Intervention: Primary stenting, best medical treatment (BMT) and exercise advice (stent group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Best medical treatment (BMT) and exercise advice alone (control group)
Number of subjects: 100
Study: 32506563

Group type: EXPERIMENTAL
Intervention: Five-session STAIR
Number of subjects: 26

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 26
Study: 36384735

Group type: EXPERIMENTAL
Intervention: multi-modal palliative care intervention
Number of subjects: 240

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 240
Study: 33716036

Group type: EXPERIMENTAL
Intervention: Modified cystoscopy (arm B)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard cystoscopy (arm A)
Number of subjects: 82
Study: 33941629

Group type: EXPERIMENTAL
Intervention: Operative treatment (open reduction and internal fixation)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Nonoperative treatment (upper limb immobilisation in long arm cast for 4 weeks)
Number of subjects: 120
Study: 32447859

Group type: EXPERIMENTAL
Intervention: Acupuncture needle inserted vertically into EX-HN7 region
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Acupuncture needle inserted obliquely upward along the inferior orbital wall
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Acupuncture needle inserted inferiorly along the orbital inferior wall
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Recommended insertion depth for acupuncture needle
Number of subjects: 28
Study: 36251300

Group type: EXPERIMENTAL
Intervention: Donanemab
Number of subjects: 272

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 272
Study: 34282575

Group type: EXPERIMENTAL
Intervention: Obese women (BMI ≥30 kg/m²)
Number of subjects: 465

Group type: COMPARATOR
Intervention: Nonobese women (BMI <30 kg/m²)
Number of subjects: 465
Study: 34338389

Group type: EXPERIMENTAL
Intervention: Increasing buprenorphine-naloxone (BUP-NX) dose in response to opioid use
Number of subjects: 270

Group type: COMPARATOR
Intervention: Constant buprenorphine-naloxone (BUP-NX) dose after week 2
Number of subjects: 270
Study: 32436633

Group type: EXPERIMENTAL
Intervention: HEAT (1 hour of light exercise in a heat chamber, 5 times a week for 5 weeks)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: HEAT
Number of subjects: 23

Group type: COMPARATOR
Intervention: CON
Number of subjects: 23
Study: 35614586

Group type: EXPERIMENTAL
Intervention: Neuromobilisation along with conservative treatment (ultrasound therapy, wrist splinting, tendon-gliding exercises)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conservative treatment (ultrasound therapy, wrist splinting, tendon-gliding exercises)
Number of subjects: 66
Study: 34948565

Group type: EXPERIMENTAL
Intervention: Copenhagen adduction exercise (CA) for 8 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 12
Study: 32517847

Group type: EXPERIMENTAL
Intervention: DBV712 250 µg
Number of subjects: 356

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 356
Study: 35164720

Group type: EXPERIMENTAL
Intervention: IPSRT-CR (Interpersonal and Social Rhythm Therapy with Cognitive Remediation)
Number of subjects: 100

Group type: COMPARATOR
Intervention: IPSRT (Interpersonal and Social Rhythm Therapy) alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: IPSRT-CR
Number of subjects: 100

Group type: COMPARATOR
Intervention: IPSRT
Number of subjects: 100
Study: 34109646

Group type: EXPERIMENTAL
Intervention: LET's CONNECT (LC)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Control group (community resource information)
Number of subjects: 218
Study: 32251146

Group type: EXPERIMENTAL
Intervention: Drilling energy
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Maximum screw compression
Number of subjects: 10
Study: 34848180

Group type: EXPERIMENTAL
Intervention: Intramuscular depot medroxyprogesterone acetate (DMPA‐IM)
Number of subjects: 829

Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG) implant
Number of subjects: 829

Group type: EXPERIMENTAL
Intervention: Copper intrauterine device (copper‐IUD)
Number of subjects: 829

Group type: COMPARATOR
Intervention: Randomized contraceptive preferences
Number of subjects: 829
Study: 33185928

Group type: EXPERIMENTAL
Intervention: Pemetrexed/cisplatin (Pem/Cis)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Vinorelbine/cisplatin (Vnr/Cis)
Number of subjects: 389
Study: 35818122

Group type: EXPERIMENTAL
Intervention: Intensive arm (8 phone sessions + 8 weeks of nicotine patches)
Number of subjects: 818

Group type: COMPARATOR
Intervention: Minimal arm (3 phone sessions + 2 weeks of nicotine patches)
Number of subjects: 818

Group type: EXPERIMENTAL
Intervention: Intensive arm
Number of subjects: 818

Group type: COMPARATOR
Intervention: Minimal arm
Number of subjects: 818
Study: 34503597

Group type: EXPERIMENTAL
Intervention: Riceberry rice (RR)
Number of subjects: 6

Group type: COMPARATOR
Intervention: White rice (WR)
Number of subjects: 6
Study: 34964149

Group type: COMPARATOR
Intervention: Galantamine 16 mg
Number of subjects: 50
Study: 33931415

Group type: EXPERIMENTAL
Intervention: Pharmacist-led mobile health intervention
Number of subjects: 136

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 136
Study: 32374959

Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy preceded by intravenous alteplase (0.9 mg/kg within 4.5 hours after symptom onset)
Number of subjects: 656

Group type: COMPARATOR
Intervention: Endovascular thrombectomy alone
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: Combination-therapy group (thrombectomy with alteplase)
Number of subjects: 656
Study: 34844423

Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy (EVT) with computed tomography perfusion (CTP) imaging
Number of subjects: 1348

Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy (EVT) without computed tomography perfusion (CTP) imaging
Number of subjects: 1348

Group type: COMPARATOR
Intervention: Best medical management (control group) with computed tomography perfusion (CTP) imaging
Number of subjects: 1348

Group type: COMPARATOR
Intervention: Best medical management (control group) without computed tomography perfusion (CTP) imaging
Number of subjects: 1348
Study: 33445505

Group type: EXPERIMENTAL
Intervention: Stretching with isometric contraction and instrument‐assisted soft tissue mobilization
Number of subjects: 21

Group type: COMPARATOR
Intervention: Instrument‐assisted soft tissue mobilization
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 21
Study: 33060370

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 441

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 441
Study: 35565845

Group type: EXPERIMENTAL
Intervention: Beet It Sport® alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beet It Sport® plus 200 mg vitamin C
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beet It Sport® plus 15 g of whey protein
Number of subjects: 0

Group type: COMPARATOR
Intervention: Beet It Sport® (all treatments)
Number of subjects: 0
Study: 34687316

Group type: EXPERIMENTAL
Intervention: Rituximab (500mg) with 12 months of antithyroid drug (ATD)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: B lymphocyte count at 28 weeks
Number of subjects: 27
Study: 35108312

Group type: EXPERIMENTAL
Intervention: Peer education based on adolescent health education (1-year duration)
Number of subjects: 1613

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1613
Study: 33073447

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Air‐abrasion before sintering (ABS)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Air‐abrasion after sintering (AAS)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Air‐abrasion before and after sintering (ABS + AAS)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fs laser before sintering (FBS)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fs laser before sintering + air‐abrasion after sintering (FBS + AAS)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fs laser after sintering (FAS)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fs laser after sintering + air‐abrasion after sintering (FAS + AAS)
Number of subjects: 80
Study: 35439582

Group type: EXPERIMENTAL
Intervention: Intensive blood glucose control (hemoglobin A1c ≤6.5%)
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control (combination of perindopril‐indapamide)
Number of subjects: 682

Group type: COMPARATOR
Intervention: Standard blood glucose control (usual care)
Number of subjects: 682

Group type: COMPARATOR
Intervention: Placebo (for blood pressure control)
Number of subjects: 682
Study: 34634101

Group type: EXPERIMENTAL
Intervention: Heart team protocol for decision-making
Number of subjects: 101
Study: 32217864

Group type: EXPERIMENTAL
Intervention: Amoxapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 0
Study: 35701080

Group type: EXPERIMENTAL
Intervention: Grape-based training models (group A)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Virtual reality modulator and silicone suture pads (group B)
Number of subjects: 83
Study: 33388987

Group type: EXPERIMENTAL
Intervention: Potassium‐competitive acid blocker (P‐CAB)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Serotonin noradrenaline reuptake inhibitor (SNRI)
Number of subjects: 52
Study: 32546262

Group type: EXPERIMENTAL
Intervention: Intravenous antibiotics plus orally administered DBT for 10 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous antibiotics plus placebo for 10 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous antibiotics plus orally administered DBT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous antibiotics plus placebo
Number of subjects: 0
Study: 35322978

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow MSCs injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 0
Study: 33982093

Group type: EXPERIMENTAL
Intervention: DDD-CLS mode
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CLS responders
Number of subjects: 20
Study: 32399578

Group type: EXPERIMENTAL
Intervention: Zinc oxide treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 30
Study: 35072641

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (6 weekly sessions, with telephone support)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 162
Study: 33255675

Group type: EXPERIMENTAL
Intervention: Harms messages
Number of subjects: 713

Group type: EXPERIMENTAL
Intervention: Messages with harm or addiction content alone
Number of subjects: 713

Group type: EXPERIMENTAL
Intervention: Flavor‐themed messages
Number of subjects: 713

Group type: EXPERIMENTAL
Intervention: Social use‐themed messages
Number of subjects: 713
Study: 35144952

Group type: EXPERIMENTAL
Intervention: Standard care plus intervention (SMS reminder messages to parents; reminders for their child’s GP from the hospital’s Paediatric Outpatients Department)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (hospital vaccine availability, ease of access and reminders for WCH subspecialists)
Number of subjects: 0
Study: 33482007

Group type: EXPERIMENTAL
Intervention: Implicit motor learning walking intervention (analogy learning)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Explicit motor learning walking intervention (detailed verbal instructions)
Number of subjects: 79
Study: 35463906

Group type: EXPERIMENTAL
Intervention: L:R (lactulose:rhamnose)
Number of subjects: 64

Group type: COMPARATOR
Intervention: L:M (lactulose:mannitol)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Circulating tTG IgA
Number of subjects: 64
Study: 35106140

Group type: EXPERIMENTAL
Intervention: Pen
Number of subjects: 755

Group type: EXPERIMENTAL
Intervention: Social incentive text cover letter
Number of subjects: 755

Group type: COMPARATOR
Intervention: No pen
Number of subjects: 755

Group type: COMPARATOR
Intervention: No social incentive text cover letter
Number of subjects: 755
Study: 36126231

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Machine Learning Algorithm (Gaussian Naïve Bayes)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Baseline BEF and anxiety status
Number of subjects: 189
Study: 32729586

Group type: EXPERIMENTAL
Intervention: 3 g intragastric tryptophan (Trp)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Volume-matched control
Number of subjects: 32
Study: 35332216

Group type: EXPERIMENTAL
Intervention: e-TNS (verum)
Number of subjects: 538
Study: 32163659

Group type: EXPERIMENTAL
Intervention: Immersive 3D interactive virtual reality (VR)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (conventional anatomy training)
Number of subjects: 72
Study: 36219307

Group type: EXPERIMENTAL
Intervention: Drawing attention to morphology group
Number of subjects: 36

Group type: COMPARATOR
Intervention: Simple spelling exposure group
Number of subjects: 36
Study: 35460310

Group type: EXPERIMENTAL
Intervention: Angelica gigas Nakai root extracts (ARE) lotion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo lotion
Number of subjects: 0
Study: 32007087

Group type: EXPERIMENTAL
Intervention: Stockholm Preterm Interaction-Based Intervention (SPIBI) - strengths-based early intervention programme with ten home visits and two telephone calls during the first year.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard follow-up and care plus extended assessment (Control group).
Number of subjects: 0
Study: 36141917

Group type: EXPERIMENTAL
Intervention: Minimally invasive radical hysterectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Robotic-assisted radical hysterectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 0
Study: 34257146

Group type: EXPERIMENTAL
Intervention: Tonsillectomy and Adenoidectomy (T/A) within 2 months (eT/A)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Tonsillectomy and Adenoidectomy (T/A) after the 12-month follow-up (T/A12)
Number of subjects: 117
Study: 34012055

Group type: EXPERIMENTAL
Intervention: SENSE program (multisensory program)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 70
Study: 32911132

Group type: EXPERIMENTAL
Intervention: Peer recovery support services (PRSS) intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 35897370

Group type: EXPERIMENTAL
Intervention: Clonazepam 0.5 mg for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tongue protector for 4 weeks
Number of subjects: 60
Study: 34551225

Group type: EXPERIMENTAL
Intervention: mRNA‐1273 vaccine (100 ?g)
Number of subjects: 30415

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30415